|
|
Programs of Previous Symposia
FIRST INTERNATIONAL SYMPOSIUM, JULY 19–23, 1992.
Speakers:
- Joseph Meites, Michigan State University, East Landing, USA —
Special Lecture:
Neuroendocrine interventions that inhibit or reverse aging processes.
- Herbert Butka, University of Vienna, Austria —
Neuropathology of aging and Alzheimer disease.
- David Bowen, Institute of Neurology and Neurochemistry, London, United
Kingdom —
Neurotransmitter receptors of ocrtical pyramidal neurons: implications
for
disorders of the aging human brain.
- Oleh Hornykiewicz, University of Vienna, Austria —
Brain aging and Parkinson disease.
- Paola Timiras, UC Berkeley, USA —
Stress and hormones alter proteins in aging neurons.
- Phyllis Wise, University of Maryland, Baltimore, USA —
Cellular mechanisms and hypothalamic aging.
- Marco Trabucchi, University of Rome, Italy —
Pharmacology of the aging brain.
- Giancarlo Pepeu, University of Florence, Italy —
Central cholinergic systems and aging.
- Agneta Nordberg, Uppsala University, Sweden —
Sexually differentiated expression of cytochrome P450C in rate liver —
a model system for studies of GH mechanisms of action.
- Gad Gilad, NIMH, Washington, DC, USA —
Effects of genotype on age related alterations in the stress induced
response of central and peripheral neuroendocrine systems.
- Engenio Müller, University of Milan, Italy —
Aspects of the neuroendocrine control of growth hormone secretion.
- Satya Kalra, University of Florida, USA —
Aging of the neuropeptidergic signals.
- Umberto Scapagnini, University of Catania, Italy —
Alteration of hypothalamic function.
- William Sonntag, Bowman Gray School of Medicine, USA —
Significance of changes in growth hormone and insulin-like growth
factors in
biological aging.
- Agneta Mode, Karolinska Institute, Sweden —
Nicotinic reeptors and aging.
- Robert Marcus, Stanford University, USA —
Effects of growth hormone in the elderly.
- Luciano Martini, University of Milan, Italy —
Aging of the neuroendocrine brain: effects on receptor mechanisms and
steroid metabolism.
- Richard Steger, Southern Illinois University, USA —
Premature aging in transgenic mice expressing different growth hormone
genes.
- Luciano Angelucci, University of Rome, Italy —
Hyppocampus and behavior.
SECOND INTERNATIONAL SYMPOSIUM, JULY 24–29, 1994.
Speakers:
- Paola Timiras, UC Berkeley, USA — Special Lecture:
Wellness in aging: streee, homeostasis and learning.
- Leonard Hayflick, UC San Francisco, USA —
Cell biology of human longevity: evidence for a telomere clock.
- Imre Zs. Nagy, University Medical School, Hungary —
Semiconduction of proteins as an attribute of the living state.
- Russel Reiter, University of Texas San Antonio, USA —
The neurohormone melatonin: its relation to the pathophysiology of
aging.
- Gilles Pierrefiche, Hospital Boucicaut, France —
Melatonin in aging and related diseases: an attempt of integrated
approach
from behavior to oxygen free radicals.
- Takayuli Ozawa, University of Nagoya, Japan —
Mitochondrial DNA mutations associated with age.
- Regina Casper, Stanford University, USA —
Nutrition and its relationship to aging.
- Edward Masoro, University of Texas San Antonio, USA —
Dietary restriction.
- Patrick Rabbit, University of Manchester, United Kingdom —
Memory changes in normal aging.
- Donald Caspary, Southern Illinois University, USA —
Neurochemical basis of auditory dysfunction with aging.
- Roger Elble, Southern Illinois University, USA —
The role of aging in the clinical expression of essential tremor.
- Vladimir Frolkis, Institute of Gerontology, Ukraine —
Role of "invertors" in the mechanisms of age-related changes of cell
response to hormones.
- C. Kaufmann, Ludwig-Bolzmann Institute, Austria —
Integrated psychotherapy in rehabilitation, especially in older age
groups.
- Clarrisa Desjardins, McGill University, Canada —
Estadiol-induced hypothalamic beta
endorphin neuron loss: a possible model of hypothalamic aging.
- Michael Meaney, McGill University, Canada —
Adrenal stress and aging.
- Diane Miller, Environmental Protection Agency, USA —
Astrogliosis in transgenic mice expressing the bovine growth hormone
gene:
indication of accelerated aging.
- Peter Reiderer, University of Würzburg, Germany —
Aging of the dopaminergic system.
- George Roth, NIA-NIH, Baltimore, USA —
Changes in tissue responsiveness to hormone and neurotransmitters
during
aging.
- Nestor Verkhratsky, Institute of Gerontology, Ukraine —
Limbic structures and their influence on endocrine gland function in
aged
rats.
- Winfred Rossmaith, University of Ulm, Germany —
Gonadotropin secretion during aging in women.
- James Carey, UC Davis, USA —
Sex-specific life table aging rates in large medfly cohorts.
- Ronald Zec, Southern Illinois University, USA —
Neuropsychology of normal human aging.
THIRD INTERNATIONAL SYMPOSIUM, JULY 21–26, 1996.
Speakers:
- Luciano Martini, University of Milan, Italy — Special Lecture:
The brain: a vulnerable target.
- Geoffrey Bennett, University of Nottingham, United Kingdom —
Effect of neuropeptides on cognitive function.
- Dolores M Catalá, Universidad de Valencia, Spain —
Parkinson Disease.
- Nicola Fabris, INRCA, Italy —
Neuroendocrine-immune interaction.
- Michael O Hengartner, Cold Spring Harbor Laboratory, USA —
Aging and apopotosis in the nematode C. elegans.
- Michel A Hofman, Netherlands Institute for Brain Research, The
Netherlands —
Lifespan changes in the human hypothalamus.
- Thomas Kirkwood, University of Manchester, United Kingdom —
Network theory of aging.
- Joseph Knoll, Semmelweis University of Medicine, Hungary —
Sexual performance and longevity.
- S M McCann, Pennington Biomedical Research Center, USA —
The nitric oxide hypothesis of brain aging.
- Arshag D Mooradian, St. Louis University Health Sciences Center, USA —
Age-related changes in the blood-brain barrier.
- Greg Morin, Geron Corporation, USA —
Telomere control of replicative lifespan.
- Hans Nohl, Veterinärmedizinische Universität Wien, Austria —
Imbalance of oxygen activation and energy metabolism as a consequence
or
mediator of aging.
- Fred Nyberg, University of Uppsala, Sweden —
Aging effects on growth hormone receptor binding in the brain.
- Meinrad Peterlik, University of Vienna, Austria —
Aging, neuroendocrine function, and osteoporosis.
- Walter Pierpaoli, Biancalana-Masera Foundation for the Aged,
Switzerland —
Circadian melatonin and young to old pineal grafting postpone aging and
maintain juvenile conditions of reproductive functions in mice and
rats.
- Yuan Touitou, Faculté de Médecine
Pitié-Salpétrière, France —
Modification of circadian and circannual rhythms with aging.
- Eugenia Wang, Bloomfield Center for Research in Aging, Canada —
Regulation of apoptosis resistance and ontogeny of age-dependent
diseases.
- Gregg Villeponteau, Geron Corporation, USA —
The heterochromatin loss model of aging.
- George Wick, University of Innsbruck, Austria —
The aging immune system: primary and secondary alterations of immune
reactivity in the elderly.
- Barry Zirkin, Johns Hopkins University, USA —
Leydig cell steroidogenesis in aging rats.
FOURTH INTERNATIONAL SYMPOSIUM, JULY 26–31, 1998.
Speakers:
- Leonard Hayflick, Univeristy of California, San Francisco, USA —
Special Lecture: How and why we age.
- Andrzej Bartke, Southern Illinois University, USA —
Does growth hormone prevent or accelerate aging?
- Christian Behl, Max Planc Institute for Psychiatry, Germany —
Effects of lgucocorticoid on exidative stree-induced hippocampal cell
death:
implications for the pathogenesis of Alzheimer disease.
- Giovanni Biggio, University of Cagliari, Italy —
Stress and neurosteroids in adult and aged rats.
- Elizabeth Bock, University of Copenhagen, Denmark —
Neural cell adhesion molecule [NCAM] in development and plasticity of
the
nervous system.
- Othmar Gaber, University of Innsbruck, Austria —
Man from Hauslabjoch.
- Ezio Giacobini, University Hospital of Geneva University , Switzerland —
Aging, Alzheimer and estrogen therapy.
- Cheryl L. Grady, Rotman Research Insitute, Canada —
Brain imaging and age-related changes in cognition.
- Beatrix Grubeck-Loebenstein, Austrian Academy of Science, Austria —
The possible role of the immune system in Alzheimer disease.
- Joe Herbert, University of Cambridge, United Kingdom —
Neurosteroids, brain damage and mental illness.
- Karen Hsiao, University of Minnesota Medical School, USA —
Transgenic mice expressing Alzheimer amyloid precursor protein.
- Donald Ingram, National Institutes on Aging, USA —
Application of gene therapy to treat age-related loss of dopamine D2
receptor.
- S. Michal Jazwinski, Louisiana State University, USA —
Genetics of longevity.
- S.M. McCann, Pennington Biomedical Research Center, USA —
Nitric oxide and aging.
- Roberto Melcangi, University of Milan, Italy —
Effects of steroid hormones on gene expression of glial markers in the
central nervous system: variations induced by aging.
- Tetsuro Miki, Osaka University Medical School, Japan —
Transcriptional activation by the Werner syndrome gene product in
yeast.
- Marilyn Millter, McGill Centre for Studies on Aging, Canada —
Estrogen, the ovary, and neurotransmitters: factors associated with
aging.
- Angelo Sagripanti, Institute of Clinical Medicine, Italy —
Natural anticoagulants, aging and thromboembolism.
- Stephen Sterns, University of Basel, Switzerland —
The experimental evolution of aging in fruitflies.
- Eva Syková, Charles University Institute of Experimental Medicine,
Czech Republic —
Diffusion contraints and neuron-glia interaction during aging.
- F. Waldhauser, University of Vienna, Austria —
Age-related changes in melatonin levels in man and their potential
consequences for sleep disorders.
FIFTH INTERNATIONAL SYMPOSIUM, JULY 23–28, 2000.
Speakers:
- Lars Bertram — Search for novel Alzheimer's disease genes – Results
of the NIMH study.
- J.M. Billard — NMDA receptor activation in aged rat hippocampus.
- Greg Brewer — Neuronal plasticity and stressor toxicity during aging.
- J.A. Edwardson — Multiple substrates of late-onset dementia:
implications for therapy.
- Ettore Ferrari — Pineal and adrenocortical function in physiological
aging and in senile dementia.
- Sam Gandy — Ovariectomy and 17 beta-estradiol modulate the levels
of Alzheimer's amyloid beta-peptides in brain.
- Siegfried Hoyer — Brain glucose and energy metabolism in sporadic
Alzheimer disease: causes and consequences.
- Akihisa Iguchi — The metabolism of plasma glucose and catecholamines in
Alzheimer's disease.
- P. Jansen-Dürr — Cell cycle regulation in aging.
- Mathias Jucker — Mouse models of brain aging and Alzheimer's disease.
- Adriana Maggi — Estrogens and apoptosis of neural cells.
- Hari Manev — 5-Lipoxygenase and cyclooxygenase mRNA expression in rat
hippocampus: early response to glutamate receptor activation by kainate.
- Alvin M. Matsumoto — Aging and the Neuroendocrine Regulation of
Reproduction and Body Weight.
- Margaret A. Pericak-Vance — Genetics of Alzheimer disease.
- John P. Phillips — Targeted neuronal gene expression and longevity in
Drosophila.
- Aurel Popa-Wagner — Brain plasticity: to what extent do aged animals
retain the capacity to coordinate gene activity in response to acute
challenges.
- Bernard Sommer — Transgenic animals as models for degenerative
diseases Mouse models of alpha-synucleinopathy and Lewy pathology.
- A. Tatariûnas — The intrinsic fluorescence of ceroid-lipofuscin
cytosomes accumulating in aging and pathology.
- Eus J.W. Van Someren — Circadian disturbances in the elderly.
- Johannes D. Veldhuis — Recent neuroendocrine facets of male
reproductive aging: an emerging feedback-network perspective.
- Bryant Villeponteau — Nutraceutical formulations to slow aging and
treat age-related diseases.
- Richard Weindruch — Caloric restriction and aging in rhesus monkey.
- John Wilmoth — Demography of longevity: Past, present, and future
trends.
SIXTH INTERNATIONAL SYMPOSIUM, JULY 21–26, 2002.
Speakers:
- In Memoriam: Eduard Schönbaum 1923–2000.
- Judith Campisi —
Special Lecture:
Cellular senescence and apoptosis: how cellular responses
might influence aging phenotypes.
- C. Bandtlow — Regeneration in the Central Nervous System.
- C. Barnes — Hippocampal aging.
- M. Gallagher — Effects of Aging on the Hippocampal Formation in a Naturally
Occurring Animal Model of Mild Cognitive Impairment.
- D. Gems — Body size, insulin/IGF signaling and ageing in the nematode
Caenorhabditis elegans.
- K. Gordon — Polycyclic phenols, estrogens and neuroprotection: A proposed
mitochondrial mechanism.
- D. Murphy
— The neuroprotective effects of estrogen on the aging brain.
- F. Lezoualc'h — Human serotonin 5-HT4 receptor and the amyloid precursor
protein [APP] processing.
- B. Lockhart — Cognition enhancing or Neuroprotective compounds for the
treatment of cognitive disorders: Why? When? Which?
- J. Macklis
— Molecular Manipulation of Neural Precursors In Situ: Induction of
Adult Cortical Neurogenesis.
- J. Mattison — Caloric restriction in Rhesus monkeys.
- F. Naftolin
— Vitamin E delays the onset of hypothalamic reproductive failure in
aging female rats.
- M. Oettel
— Selective aspects of endocrine pharmacology of the aging male.
- H. Ooboshi — Brain ischemia as a potential target of gene therapy.
- B. Pakkenberg — Aging and the human neocortex.
- G. Paolisso
— Glucose regulation and oxidative stress in healthy centenarians.
- M. Racchi — The pharmacology of amyloid precursor protein.
- C. Rauser — Aging, fertility and immortality.
- D. Skene — Melatonin rhythmicity: effect of age and Alzheimer's disease.
- J. Syka — Auditory system and aging.
- R. Verwer — In vitro studies on adult human post mortem brain tissue in relation
to aging.
- G. Wick — A Darwinian-evolutionary concept of age-related diseases.
- A. Wirz-Justice — Dawn-dusk Simulation Light Therapy of Disturbed Circadian
Rest-activity Cycles in Demented Elderly.
- J. Zimmerman — Nutritional control of aging.
SEVENTH INTERNATIONAL SYMPOSIUM, JULY 18–23, 2004.
Speakers:
-
C. Dominique Toran-Allerand, New York, New York, USA —
Special Lecture:
Estrogen and the Brain: Beyond ER-alpha and ER-beta
-
Alexander Bürkle, Konstanz, Germany —
Poly ADP Ribosylation and Aging
-
Natalia Danilovich, Montreal, Canada —
Role of the FSH Receptor in Reproductive Senescence and Biological
Aging in Mice
-
Luis-Miguel Garcia-Segura, Madrid, Spain —
Sex Hormones and Brain Aging
-
Nestor Gonzalez-Cadavid, Torrance, California, USA —
Gene Therapy and Erectile Dysfunction
-
Jan-Ake Gustafsson, Huddinge, Sweden —
The Role of the Estrogen Receptor Beta in Neuroprotection
-
Nobuyoshi Hirose and Toshio Kojima, Tokyo, Japan —
Neurotransmitter Function in Centenarians
-
Eef Hogervorst, Oxford, UK —
Testosterone and Alzheimer's Disease
-
Martin Holzenberger, Paris, France —
IGF-1 Signaling and Aging
-
Xudong Huang, Charlestown, Massachusetts, USA —
Novel Alzheimer's Aß
Metallobiochemistry and its therapeutic implication
-
Ilpo Huhtaniemi, London, U.K. —
Genetic Polymorphisms and Male Aging
-
Pidder Jansen-Dürr, Innsbruck, Austria —
Oxidative Stress in Endothelial Cell Aging
-
Kay Lund, Chapel Hill, North Carolina, USA —
Transcriptional Mechanisms of Hippocampal Aging and Memory Loss
-
Michal Karasek, Lodz, Poland —
Melatonin, Human Aging, and Age-related Diseases
-
Mary Ann Ottinger, College Park, Maryland, USA —
Reproductive Aging in Birds
-
Vladimir Patchev, Jena, Germany —
Neurotropic Action of Androgens: Principles and Mechanisms
-
Thomas Perls, Boston, Massachusetts, USA —
Exceptional Longevity in the Human
-
Pat Prinz, Seattle, Washington, USA —
Sleep Impairments in Healthy Seniors
-
Michael Rowan, Dublin, Ireland —
Mechanism of the Effects of Amyloid Beta-Protein Oligomers on Synaptic
Efficacy
-
Marc Tatar, Providence, Rhode Island, USA —
Endocrine Regulation of Aging in Drosophila
-
Klaus Turnheim, Vienna, Austria —
Drug Therapy in the Elderly
-
Monique Vallee, Bordeaux, France —
Neuroactive Steroids: New Markers of Cognitive Aging
EIGHTH INTERNATIONAL SYMPOSIUM, JULY 23–28, 2006.
Speakers:
- Greg M. Cole, USA —
Special Lecture:
Insulin resistance, TZDs and aging
- Bart Braeckman, Belgium —
Genetic control of longevity in C. elegans
- Alessandro Cellerino, Italy —
Aging in a short-lived annual fish
- Francesca Cirulli, Italy —
p66Shc-/- mouse as a model to study susceptibility to stress and aging
- Ana Maria Cuervo, USA —
Alpha-synuclein and autophagy
- Krishnan M. Dhandapani, USA —
TGF-beta and neuroprotection
- Christopher Heward, USA —
Developing a SNP-based test for Alzheimer's Disease
- Ilpo Huhtaniemi, UK —
The impact of polymorphisms in genes regulating
pituitary-gonadal function on gender-specific aging of
European men
- Felix Kreier, The Netherlands —
Hypothalamus – leptin and hypothalamic function
- Anthony LaMantia, USA —
Neurogenesis
- Frederic Mery, Switzerland —
Trade offs in long-term memory formation
- Alon Monsonego, Israel —
Immunotherapy of Alzheimer's disease
- Lisa Mosconi, USA —
Early detection of Alzheimer's disease
- Gerald Muench, Australia —
Advanced glycation products
- Antonio Musarò, Italy —
Neuroprotective effects of a local isoform of IGF-1
- Linda Partridge, UK —
Fecundity versus longevity
- George Roth, USA —
Caloric restriction mimetics: the next phase
- Norman Sharpless, USA —
Cancer and tumor suppressors
- Csaba Söti, Hungary —
Protein toxicity and cellular defense mechanisms: the role of chaperones
- Robert G. Struble, USA —
Estrogens and glial function
- Georg Wick, Austria —
Atherosclerosis Risk-factors in Female Youngsters (ARFY) Study
- Judy Wong, Canada —
Role of Chromosome Maintenance in Human Disease and Aging
NINTH INTERNATIONAL SYMPOSIUM, JULY 20–25, 2008.
Speakers:
- Elizabeth Blackburn, San Francisco, CA, USA —
Special Lecture:
Telomeres and telomerase: their implication in human age-related diseases
- Dorothee P. Auer, Nottingham, UK —
Brain imaging in Alzheimer and Parkinson's diseases
- Nir Barzilai, Bronx, NY, USA —
Central regulation of peripheral insulin action
- Holly Brown-Borg, Grand Forks, ND, USA —
Long-living growth hormone receptor knock out mice:
Potential mechanisms of altered stress resistance
- José M. Carrascosa, Madrid, Spain —
Changes in the neuroendocrine control of energy homeostasis by
adiposity signals during aging
- Terry Combs, Chapel Hill, NC, USA —
Neuroendocrine Inhibition of Glucose Production and Resistance to Cancer
in Dwarf Mice
- Alejandro F. De Nicola, Buenos Aires, Argentina —
Steroid protection
- Ettore Ferrari, Pavia, Italy —
Pineal, adrenocortical and thyroid function in autonomous
centenarians
- Luigi Fontana, St. Louis, MO, USA & Rome, Italy —
Neuroendocrine Factors in the Regulation of Inflammation:
Excessive Adiposity and Calorie Restriction
- Laura Fratiglioni, Stockholm, Sweden —
Prevention of common neurodegenerative disorders in the elderly
- Lance J. Kriegsfeld, Berkeley, CA, USA —
Reproductive aging
- Günter Lepperdinger, Innsbruck, Austria —
Leptin receptor/CD295 is upregulated on primary
human mesenchymal stem cells of advancing biological
age and distinctly marks the subpopulation of dying cells
- Paweł Liberski, Łódź, Poland —
Kuru: its ramifications after fifty years
- Valter D. Longo, Los Angeles, CA, USA —
Linking Sirtuins, IGF-I signaling, and Starvation
- K. Lenhard Rudolph, Ulm, Germany —
Cell intrinsic and extrinsic mechanisms of stem cell aging depend
on telomere status
- Thomas Samaras, San Diego, CA, USA —
The Role of Height in Human Longevity
- Heidi Scrable, Charlottesville, VA, USA —
Running on empty: how p53 controls INS/IGF signaling and affects lifespan
- Natalie Sampson, Austrian Academy of Sciences, Austria —
Integrated networks of sex steroid hormone metabolism and cytokine
signalling in the
pathogenesis of age-related prostatic disease
- LaDora Thompson, Minneapolis, MN, USA —
Mechanisms of sarcopenia during mammalian aging
- Aleksandra Trifunovic, Stockholm, Sweden —
Somatic mtDNA mutations and ageing – facts and fancies
- Rudi Westendorp, Leiden, The Netherlands —
The influence of age on the association between cholesterol and
cognitive function
TENTH INTERNATIONAL SYMPOSIUM, JULY 25–30, 2010.
Speakers:
- Greti Aguilera, Bethesda, MD, USA —
HPA axis responsiveness to stress: Implications for ageing and well-being
- Craig Atwood, Madison, WI, USA —
Testing the Reproductive-Cell Cycle Theory of Aging
- Andrzej Bartke, Springfield, IL, USA —
Insulin signaling, calorie restriction & aging
- Christian Benedict, Uppsala, Sweden —
Intranasal Insulin: A future therapy to improve cognition
in patients suffering from Alzheimer's disease?
- Rochelle Buffenstein, San Antonio, TX, USA —
Attenuated aging in the long-living naked mole-rat;
endocrine and neurobiological changes
- Rafael de Cabo, Bethesda, MD, USA —
Calorie Restriction: Is It All About Appetite?
- Monica Driscoll, Piscataway, NJ, USA —
Healthspan Genetics and Tissue-specific Aspects of Age-Associated Decline:
Worm Secrets for Healthy Aging
- Ehud Cohen, Jerusalem, Israel —
The insulin/IGF1 signaling pathway couples aging and neurodegeneration:
from worms to mice
- Rita Effros, Los Angeles, CA, USA —
Telomere/telomerase dynamics in the immune system: effects of
chronic infection and stress
- Thomas Flatt, Vienna, Austria —
Endocrine Regulation of the Trade-Off between Lifespan and
Reproduction in Drosophila
- Don Ingram, Baton Rouge, LA, USA —
Glycolytic Inhibition as a Strategy for Developing Calorie Restriction Mimetics
- Brian Kennedy, Seattle, WA, USA —
Longevity pathways and Age-related disease
- Gordon Lithgow, Novato, CA, USA —
Common mechanisms of neurodegeneration and aging suggested by
genes and chemical manipulation of lifespan
- Bernd Moosmann, Mainz, Germany —
Evolutionary proteomic adaptations towards longevity and
stress resistance in animals
- Marie-Christine Pardon, Nottingham, UK —
Retardation of Alzheimer's-like pathology by mild stressors
- Clemens Steegborn, Bochum, Germany —
Molecular mechanisms that modulate mitochondrial lifespan
regulator proteins
- Dick Swaab, Amsterdam, Netherlands —
Aging and dementia in hypothalamic systems: functional consequences
- Ignacio Torres-Aleman, Madrid, Spain —
IGF-1 in the aging brain
- Eleni Tzima, UNC, USA —
The role of hemodynamic forces in endothelial dysfunction and vascular aging
- Alexander Vaiserman, Kiev, Ukraine —
Early-life etiology of age-related diseases: epidemiological evidence
- Holly Van Remmen, San Antonio, TX, USA —
Oxidative stress induced alterations in skeletal muscle and
neuromuscular junctions during aging
- Barbara Viviani, Milan, Italy —
Cytokines and neuronal channels: a molecular basis for
age-related decline of neuronal function?
|
|